Skip to main content
DNA Labs India

GRN Gene Dementia, frontotemporal NGS Genetic Test

DNA Labs India | ISO 9001:2015 Certified

GRN Gene Dementia, frontotemporal NGS Genetic Test

Short Name: GRN FTD NGS Test

Also known as: GRN Gene Mutation Test, Progranulin Gene Sequencing, Frontotemporal Dementia Genetic Panel, GRN NGS Analysis

GRN Gene Dementia, frontotemporal NGS Genetic Test test available at DNA Labs India for ₹20,000. Uses Next-Generation Sequencing (NGS) on Blood or Extracted DNA or One drop Blood on FTA Card samples. Results in The test reports will be delivered within 3 to 4 weeks from the date of sample receipt. Reports are uploaded to the patient portal and shared via email/WhatsApp.. Free home collection in 300+ cities across India.

NGS Genetic TestAdult🏠 Home Collection

🩺 Medically Reviewed By

Overview

The purpose of the GRN gene frontotemporal NGS genetic test is to identify pathogenic variants in the GRN gene that are associated with frontotemporal dementia. It aids in confirming a clinical diagnosis, differentiating FTD from other dementia subtypes, providing information about disease prognosis, and enabling predictive testing for at-risk family members. The test also supports clinicians in making informed management decisions and in counseling families regarding recurrence risk.

Test Code
3997
CPT Code
81413
ICD Code
G31.09
Price
₹20,000
Sample Type
Blood or Extracted DNA or One drop Blood on FTA Card
Result Time
The test reports will be delivered within 3 to 4 weeks from the date of sample receipt. Reports are uploaded to the patient portal and shared via email/WhatsApp.
Fasting Required
No
Method
Next-Generation Sequencing (NGS)
Step 1

Sample Collection

No fasting is required. Please carry a valid government ID and any previous medical reports or imaging scans. It is recommended to complete the genetic counseling session before sample collection.

Method: Peripheral Venipuncture / FTA Card Blood Spot

Step 2

Laboratory Analysis

The sample will be collected by a trained phlebotomist using sterile methods. If using an FTA card, a few drops of capillary blood will be spotted onto the card. The procedure is quick and virtually painless.

Step 3

Report Delivery

You may resume all normal activities immediately after sample collection. No special precautions are required. The sample will be transported to our laboratory under temperature-controlled conditions.

Timeline: The test reports will be delivered within 3 to 4 weeks from the date of sample receipt. Reports are uploaded to the patient portal and shared via email/WhatsApp.

Patient Instructions

1
Before the Test:Pre-test genetic counseling is mandatory. The counselor will review your family history, clarify the benefits and risks of genetic testing, and obtain informed consent before ordering the test.
2
During the Test:No special measures are required. The sample is processed in a NABL accredited laboratory using validated NGS technology. Clinical details and a pedigree chart are used alongside sequencing for interpretation.
3
After the Test:Post-test genetic counseling is essential to understand your results. You will be guided about the impact of the result on your health, options for risk reduction, and implications for blood relatives.

About This Test

Who Should Get This Test

The purpose of the GRN gene frontotemporal NGS genetic test is to identify pathogenic variants in the GRN gene that are associated with frontotemporal dementia. It aids in confirming a clinical diagnosis, differentiating FTD from other dementia subtypes, providing information about disease prognosis, and enabling predictive testing for at-risk family members. The test also supports clinicians in making informed management decisions and in counseling families regarding recurrence risk.

How to Prepare

  • Please inform us if you have had a bone marrow transplant or blood transfusion in the past 6 months.
  • For home collection, ensure an adult is present at the time of collection.
  • If you have received blood products recently, consider postponing genetic testing to avoid DNA contamination.

Doctor's Notes

Reviewed by — MBBS, MD (Medical Genetics) · Reg. No. 8532

"Genetic counseling before testing is essential to assess inheritance patterns and discuss implications for family members."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeBlood or Extracted DNA or One drop Blood on FTA Card
Sample Volume2-3 ml
ContainerEDTA tube or FTA card
Collection MethodPeripheral Venipuncture / FTA Card Blood Spot

Sample Stability

EDTA blood: 7 days at 2–8°C
Extracted DNA: 6 months at -20°C
FTA card: 12 months at ambient temperature
Sample Rejection Criteria:
  • Haemolysed or clotted blood samples
  • Samples received without proper labeling or consent
  • Samples shipped at room temperature for more than 7 days
  • Inadequate DNA quantity or quality for NGS

Understanding Your Results

The clinical report will indicate whether a pathogenic variant in the GRN gene was identified. Interpretation should be performed by a clinical geneticist in the context of the patient's symptoms, family history, and other clinical findings.
📊

Pathogenic variant detected

The variant is disease-causing and confirms the genetic basis of frontotemporal dementia. Predictive testing of at-risk relatives is indicated with genetic counseling.

📊

Likely pathogenic variant detected

The variant is likely to cause disease. Confirmatory testing or additional evidence may be required. Clinical correlation is essential.

📊

Variant of uncertain significance (VUS)

The significance of the variant is unknown. Further segregation analysis, functional studies, and consultation with a geneticist are recommended.

📊

No pathogenic variant detected

No disease-causing mutation was identified in the GRN gene. This does not exclude other genetic causes of FTD. Consider broader testing if clinical suspicion is high.

⚠️ When to Consult a Doctor:

If you or a family member experience early-onset behavioral changes, language difficulties, or memory problems suggestive of frontotemporal dementia, you should consult a neurologist. If a hereditary cause is suspected, ask for a referral to a genetic specialist or memory disorders clinic.

Limitations

  • This test detects mutations in the GRN gene only and does not rule out other genes involved in frontotemporal dementia such as MAPT, C9orf72, TARDBP, or FUS.
  • The test does not measure progranulin protein levels; a functional assay may be recommended separately.
  • Some non-coding or deep intronic variants may not be detected by standard NGS.
  • Large deletions or duplications in the GRN gene may require additional MLPA analysis.
  • Variant classification may change as new research emerges.
  • Predictive testing in asymptomatic individuals requires pre- and post-test genetic counseling and should not be performed in minors unless clinically indicated.

Risks & Considerations

  • Genetic testing may reveal unexpected information about family relationships.
  • Psychological distress after learning a positive or inconclusive result.
  • Potential discrimination by insurers or employers if disclosed; however, the Genetic Information Non-Discrimination Act provides some protections in India.
  • Predictive test results may affect insurability and family dynamics.

Interfering Factors

  • Poor quality or degraded DNA sample
  • Contaminated blood samples or non-sterile collection
  • Incomplete clinical information or pedigree
  • Chimeric or bone marrow transplantation history
  • Rare technical artifacts in NGS requiring confirmatory Sanger sequencing

Compare With Similar Tests

TestGRN Gene Dementia, frontotemporal NGS Genetic Test
ComparisonGRN Gene Dementia, frontotemporal NGS Genetic Test

Frequently Asked Questions

What is the GRN gene and how is it related to frontotemporal dementia?
The GRN gene provides instructions for making progranulin, a protein that supports nerve cell survival. Mutations in GRN reduce progranulin levels, causing frontotemporal dementia. Testing for GRN mutations is recommended when FTD runs in a family.
What is the cost of the GRN gene frontotemporal NGS genetic test in India?
At DNA Labs India, the cost is Rs 20,000. This includes free home sample collection, genetic counseling, NGS sequencing of the GRN gene, and a detailed clinical report along with raw data files.
What sample is needed for this test?
We accept 2-3 ml of whole blood in an EDTA tube, extracted DNA, or a single drop of blood spotted on an FTA card. The sample can be collected at home or at a sample collection center.
Do I need to fast before giving a sample?
No, fasting is not required for this genetic test. You can eat and drink normally before sample collection.
How long will it take to get the test results?
The turnaround time is 3 to 4 weeks from the date the sample reaches our laboratory. We share the report via email, WhatsApp, and the patient portal.
Will I get the raw data files (FASTQ and VCF)?
Yes, DNA Labs India is the only lab that provides raw data files (FASTQ and VCF) along with the conclusive clinical report. This allows transparency and permits secondary analysis by the patient or their physician.
Is genetic counseling required before the test?
Pre-test genetic counseling is mandatory. It helps you understand the purpose, implications, and limitations of the test. A counselor will also draw a pedigree chart of affected family members and discuss inheritance risks.
Can this test detect all mutations in all genes associated with FTD?
No, this test specifically analyzes the GRN gene. Other FTD-related genes like MAPT and C9orf72 are not covered by this test. If your clinical picture suggests a broader genetic cause, consider a comprehensive FTD panel.
What does a negative GRN test result mean?
A negative result means no pathogenic variant was identified in the GRN gene. It does not exclude frontotemporal dementia, as mutations in other genes or non-genetic causes can be responsible. Your doctor may recommend further testing.
Can the test be done on a presymptomatic person with a family history?
Yes, predictive testing is possible with proper genetic counseling and informed consent. The individual must be at least 18 years old and should be mentally prepared to receive the result.
Is this test covered by insurance?
Most insurance schemes in India do not cover genetic tests, including GRN NGS testing. However, some private insurance policies may partially reimburse if prescribed by a specialist. It is best to check with your insurer.
What is the difference between GRN gene testing and C9orf72 testing?
GRN gene testing uses NGS to find point mutations in the GRN gene, while C9orf72 testing detects an abnormal expansion of a repeat sequence in the C9orf72 gene. Both are common causes of FTD and may be tested separately or together in a panel.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.